Table 2.
Characteristics | |
---|---|
Total | 36 |
Female, n (%) | 25 (70) |
White, n (%) | 34 (94.4) |
LS subtype, n (%) | |
Linear extremity | 12 (33.3) |
Linear face/scalp | 6(16.7) |
Generalized morphea | 5(13.9) |
Mixed (linear and GM) | 7(19.4) |
Subcutaneous morphea | 3 (8.3) |
Plaque morphea | 3 (8.3) |
Age at onset, yrs, median (IQR) | 7.86(4.63–11.91) |
Age at last followup, yrs, median (IQR) | 13.15(9.89–16.61) |
Disease duration before therapy started, mo, median (IQR) | 19.15(8.96–35.35) |
Duration of followup, mo, median (IQR) | 36.40 (29.39–45.36) |
GM: generalized morphea; IQR: interquartile range.